Browsing byAuthorBeretov, J
Showing results 1 to 5 of 5
Issue Date | Title | Author(s) |
2021-07 | Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis. | Bai, X; Ni, J; Beretov, J; Wasinger, VC; Wang, S; Zhu, Y; Graham, P; Li, Y |
2022-07 | ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo. | Law, AMK; Chen, J; Colino-Sanguino, Y; Fuente, LRDL; Fang, G; Grimes, SM; Lu, H; Huang, RJ; Boyle, ST; Venhuizen, J; Castillo, L; Tavakoli, J; Skhinas, JN; Millar, EKA; Beretov, J; Rossello, FJ; Tipper, JL; Ormandy, CJ; Samuel, MS; Cox, TR; Martelotto, L; Jin, D; Valdes-Mora, F; Ji, HP; Gallego-Ortega, D |
2019 | CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target. | Feng, X; Bai, X; Ni, J; Wasinger, VC; Beretov, J; Zhu, Y; Graham, P; Li, Y |
2021-04-15 | Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model. | Behary, J; Raposo, AE; Amorim, NML; Zheng, H; Gong, L; McGovern, E; Chen, J; Liu, K; Beretov, J; Theocharous, C; Jackson, MT; Seet-Lee, J; McCaughan, GW; El-Omar, EM; Zekry, A |
2021-11-03 | Multiplexed immunofluorescence identifies high stromal CD68+PD-L1+ macrophages as a predictor of improved survival in triple negative breast cancer. | Wang, J; Browne, L; Slapetova, I; Shang, F; Lee, K; Lynch, J; Beretov, J; Whan, R; Graham, PH; Millar, EKA |